Correction: Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer

Correction: Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-06-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/9/6/e001717corr1.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

TOPOMETRIC PREPARATION AND PLANNING OF NEOADJUVANT RADIOTHERAPY IN THE COMPLEX TREATMENT OF RECTAL CANCER
by: B. V. Luc
Published: (2022-09-01)

Author Correction: Reprogramming the tumor immune microenvironment using engineered dual-drug loaded Salmonella
by: Dinh-Huy Nguyen, et al.
Published: (2025-01-01)

Reprogramming the tumor immune microenvironment using engineered dual-drug loaded Salmonella
by: Dinh-Huy Nguyen, et al.
Published: (2024-08-01)

Viral mimicry evasion: a new role for oncogenic KRAS mutations
by: Raymond Chen, et al.
Published: (2025-02-01)

Tumor microenvironment remodeling after neoadjuvant chemoradiotherapy in local advanced rectal cancer revealed by single-cell RNA sequencing
by: Wenzhao Su, et al.
Published: (2024-11-01)

Audio Mimicry: An Adjunct to Color Mimicry
by: Albro T. Gaul
Published: (1952-01-01)

Targeting WDxR motif reprograms immune microenvironment and inhibits hepatocellular carcinoma progression
by: Heng Zhang, et al.
Published: (2023-03-01)

Radiotherapy & total neoadjuvant therapy for recurrent rectal cancer in previously irradiated patients, (RETRY): a multicenter prospective observational study
by: Maria Antonietta Gambacorta, et al.
Published: (2024-12-01)

N6-methyladenosine RNA methylation, a new hallmark of metabolic reprogramming in the immune microenvironment
by: Xiaoyue Li, et al.
Published: (2024-12-01)

PCK1 as a target for cancer therapy: from metabolic reprogramming to immune microenvironment remodeling
by: Na Liu, et al.
Published: (2024-11-01)

Comparison of the tumor immune microenvironment phenotypes in different breast cancers after neoadjuvant therapy
by: Mengxue Han, et al.
Published: (2023-02-01)

Perioperative Radiotherapy in the Management of Rectal Cancer
by: Lars Påhlman
Published: (2001-01-01)

Neoadjuvant chemoradiotherapy in combined treatment of patients with rectal cancer
by: N. A. Maistrenko, et al.
Published: (2017-08-01)

Mimicry in Hemiptera
by: Edward p. van Duzee
Published: (1888-01-01)

Cross-Sectional National Survey of Practice Patterns in Radiotherapy for Rectal Cancer: A Snapshot of India
by: Rahul Krishnatry, et al.
Published: (2024-11-01)

Exploring the attenuating effect of amifostine on neoadjuvant radiotherapy with concurrent use of irinotecan for locally advanced rectal cancer: a retrospective cohort study of 154 cases
by: CHU Yajuan, ZHANG Lei, LI Yunhai, LUO Weiming, ZHANG Jing, MO Xiaochen, MA Jinli
Published: (2024-10-01)

Viral status, immune microenvironment and immunological response to checkpoint inhibitors in hepatocellular carcinoma
by: Hao Wang, et al.
Published: (2020-05-01)

Neoadjuvant therapy in rectal cancer—one year follow-up results of standard versus total neoadjuvant strategies
by: Luís Correia Gomes, et al.
Published: (2024-11-01)

Epitopedia: identifying molecular mimicry between pathogens and known immune epitopes
by: Christian A Balbin, et al.
Published: (2023-03-01)

Correction: Targeting IL-33 reprograms the tumor microenvironment and potentiates antitumor response to anti-PD-L1 immunotherapy
Published: (2024-11-01)

Defensive Mimicry in Phalangidae
by: George Dimmock
Published: (1882-01-01)

Total neoadjuvant therapy in rectal cancer: a review across studies
by: Gavalas Ioannis, et al.
Published: (2024-04-01)

Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC
by: Thomas Karn, et al.
Published: (2020-10-01)

Correction: Short-course radiotherapy promotes pro-inflammatory macrophages via extracellular vesicles in human rectal cancer
Published: (2020-10-01)

Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis
by: Jian Zhang, et al.
Published: (2022-03-01)

Immune microenvironment features underlying the superior efficacy of neoadjuvant immunochemotherapy over chemotherapy in local advanced gastric cancer
by: Ning Zhang, et al.
Published: (2025-01-01)

Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer
by: Renee N Donahue, et al.
Published: (2020-05-01)

Oxidative Stress, Tumor Microenvironment, and Metabolic Reprogramming: A Diabolic Liaison
by: Tania Fiaschi, et al.
Published: (2012-01-01)

A comprehensive analysis of vasculogenic mimicry related genes to predict the survival rate of HCC and its influence on the tumor microenvironment
by: Jingyun Wang, et al.
Published: (2024-12-01)

Copper-coordination driven brain-targeting nanoassembly for efficient glioblastoma multiforme immunotherapy by cuproptosis-mediated tumor immune microenvironment reprogramming
by: Yang Chen, et al.
Published: (2024-12-01)

Role of mast cell in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
by: Masaaki Nishi, et al.
Published: (2025-01-01)

Hemoglobin Level as a Prognostic Factor of Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer
by: Berrin Yalçın, et al.
Published: (2024-11-01)

Titin gene mutations enhance radiotherapy efficacy via modulation of tumour immune microenvironment in rectum adenocarcinoma
by: Hengchang Liu, et al.
Published: (2025-01-01)

Metabolic reprogramming and immunological changes in the microenvironment of esophageal cancer: future directions and prospects
by: Zhi-Xun Guo, et al.
Published: (2025-01-01)

Reprogramming the tumor microenvironment – macrophages emerge as key players in breast cancer immunotherapy
by: Ana Sami, et al.
Published: (2024-11-01)

Texture Analysis and Prediction of Response to Neoadjuvant Treatment in Patients with Locally Advanced Rectal Cancer
by: Ilaria Mariani, et al.
Published: (2024-10-01)

Immunogenic cell death inducers and PD-1 blockade as neoadjuvant therapy for rectal cancer
by: Yan Wang, et al.
Published: (2024-12-01)

Dosimetric comparison of VMAT plans in preoperative short-course rectal radiotherapy
by: Qiong Zhou, et al.
Published: (2024-12-01)

ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma
by: Hui Wang, et al.
Published: (2020-05-01)

Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic
by: Maite Alvarez, et al.
Published: (2023-12-01)